Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Sutro Biopharma, Inc. (STRO)

Canton Strategic Holdings, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Canton Strategic Holdings, Inc. and Sutro Biopharma, Inc. are of similar size ($172.1M and $164.8M). Canton Strategic Holdings, Inc. has the higher net margin (0.00% vs −395.3%) and the lower return on invested capital (−8.11% vs 0.00%). Across the 11 metrics below, Canton Strategic Holdings, Inc. leads on 9 and Sutro Biopharma, Inc. on 2.

Valuation

Metric CNTN STRO Biotechnology median
P/E n/m n/m 10.26
P/S n/m 3.34 9.18
P/B 0.92 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.03 0.65
EV/Sales n/m (0.08) 8.98
Earnings yield (47.53%) (187.89%) (34.89%)
Free cash flow yield (5.32%) (95.31%) (24.52%)

Profitability

Metric CNTN STRO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity (43.10%) 266.76% (50.12%)
Return on assets (34.60%) (79.08%) (45.60%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN STRO Biotechnology median
Revenue growth (TTM) — (56.25%) 6.26%
EPS growth (last fiscal year) 88.10% 24.02% 29.88%
Revenue growth, 5-year CAGR — 19.12% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 3.32 4.89
Net debt to EBITDA 0.85 0.92 1.01

Dividend

Metric CNTN STRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTN STRO Biotechnology median
Market cap 172.11m 164.82m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack